Work

Bridging Gaps in Evidence-based Clinical Practice in Inflammatory Bowel Diseases: Observational Comparative Effectiveness Research for the Win

Year: 2019

Type: editorial

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2018.12.047

Authors: Frank I. Scott, Siddharth Singh

Institutions: University of Colorado Anschutz, University of California San Diego

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Pfizer, AbbVie, Takeda Pharmaceuticals U.S.A., American College of Gastroenterology, Crohn's and Colitis Foundation, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Janssen Pharmaceuticals

Awards: G2115790953, Microvascular disease, statins, ACE-inhibitors and post-operative SBO, G4464589005, Comparative Risks and Benefits of Pharmacological Therapies for Older Patients with Inflammatory Bowel Diseases

OpenAlex ID: W2908612893

Cites: 21

Cited by: 2

Related to: 10